Metabolex Passes $200 Million Mark
Metabolex Inc., a Hayward, Calif.-based drug company focused on diabetes and other metabolic disorders, has raised $8.6 million in fifth-round funding. Return backers include Alta Partners, Venrock, Versant Ventures, Bay City Capital, VantagePoint Venture Partners, Novo Ventures, Pictet, Next Chapter Holdings, Charter Ventures, Merlin Biomed and Birchmere Ventures. The company previously raised around $196 million in total VC funding since 1996, including a 2003 financial restructuring.
6 November 2009•2 mins read
